EXHIBIT 31.2

 

CERTIFICATION BY OFFICER

 

I, Steve O’Loughlin, certify that:

 

1. I have reviewed this Amendment No. 1 to Form 10-K for the year ended December 31, 2025 of CNS Pharmaceuticals, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   

 

Date: April 30, 2026 By: /s/ Steve O’Loughlin
    Chief Financial Officer
    (Principal Financial and Accounting Officer)